```html

Acute Urinary Retention (AUR)

Overview

Acute urinary retention (AUR) is the sudden, painful inability to pass urine despite a full bladder. It is considered a urological emergency because the bladder can become over‑distended within hours, leading to tissue damage and infection.

Who it affects

• Men over 50 – most cases are linked to prostate enlargement (benign prostatic hyperplasia, BPH).
• Women – often due to postoperative effects, medications, or severe constipation.
• People with neurologic disease (multiple sclerosis, spinal cord injury, Parkinson’s disease).
• Patients who have recently undergone surgery, especially pelvic or lower‑abdominal procedures.

Prevalence

• In the United States, an estimated 150,000–200,000 emergency‑department visits per year are for AUR.
• Incidence rises sharply after age 50, affecting roughly 10 % of men with BPH each year (Mayo Clinic, 2023).

Symptoms

The hallmark of AUR is an abrupt inability to void, usually with intense suprapubic pain. Associated symptoms may include:

• Urgent, painful urge to urinate with no flow.
• Abdominal (suprapubic) fullness or distension – the bladder can feel like a hard ball.
• Lower‑back or pelvic pain radiating to the perineum.
• Swelling of the lower abdomen visible in severe cases.
• Cloudy, foul‑smelling urine if a urinary tract infection (UTI) is present.
• Fever, chills, or malaise – signs of possible infection or sepsis.
• Nausea or vomiting – especially in elderly patients.
• Reduced urine output after catheter removal (post‑obstructive diuresis).

Causes and Risk Factors

Mechanical Obstruction

• Benign prostatic hyperplasia (BPH) – most common cause in men.
• Prostate cancer or prostate surgery (e.g., transurethral resection).
• Urethral stricture – scar tissue narrowing the urethra.
• Bladder stones or large urinary calculi that block the outlet.
• Pelvic organ prolapse in women (cystocele compressing the urethra).

Functional (Neurogenic) Causes

• Spinal cord injury, spinal stenosis, or multiple sclerosis.
• Parkinson’s disease or other neurodegenerative disorders.
• Severe diabetic autonomic neuropathy.
• Medications that relax detrusor muscle (see below).

Medication‑Induced Retention

• Anticholinergics (e.g., oxybutynin, diphenhydramine).
• Alpha‑adrenergic agonists (e.g., pseudoephedrine, decongestants).
• Opioids and narcotic analgesics.
• Sedatives and hypnotics (e.g., benzodiazepines).
• Antidepressants with strong anticholinergic properties.

Other Risk Factors

• Recent pelvic or abdominal surgery, especially with epidural anesthesia.
• Severe constipation or fecal impaction compressing the urethra.
• Trauma to the pelvis or perineum.
• Advanced age – reduced bladder contractility.
• History of previous urinary retention episodes.

Diagnosis

Prompt recognition is essential. The diagnostic work‑up includes a focused history, physical exam, and targeted tests.

Clinical Evaluation

1. History – onset, pain severity, recent surgeries, medication list, neurologic conditions.
2. Physical exam – palpation of a distended bladder, assessment for suprapubic tenderness, digital rectal exam (to evaluate prostate size in men).
3. Bladder scan – a portable ultrasound that estimates post‑void residual volume (PVR). A PVR > 300 mL is highly suggestive of AUR.

Laboratory and Imaging Tests

• Urinalysis – looks for infection, hematuria, or crystals.
• Serum creatinine & blood urea nitrogen (BUN) – to assess renal function, which can be impacted by prolonged retention.
• Catheterized urine culture – if infection is suspected.
• Trans‑abdominal ultrasound – confirms bladder volume and checks for obstructive lesions.
• Urodynamic studies – reserved for recurrent or chronic cases, not for the acute emergency.
• CT or MRI – may be indicated if a mass, stone, or neurological cause is suspected.

Treatment Options

Immediate decompression of the bladder is the first priority, followed by addressing the underlying cause.

Urgent Decompression

• Foley catheter placement – a sterile, indwelling catheter inserted through the urethra to drain urine. Success rates exceed 95 %.
• Intermittent (in‑and‑out) catheterization – used when short‑term drainage is preferred.
• Suprapubic catheter – placed percutaneously if urethral catheterization fails (e.g., severe obstruction, urethral trauma).

Medication Management

• Alpha‑blockers (e.g., tamsulosin, alfuzosin) – relax smooth muscle in the prostate/bladder neck, facilitating voiding. Begin within 24 hrs after catheter removal.
• 5‑alpha‑reductase inhibitors (finasteride, dutasteride) – shrink prostate size over months; used for chronic BPH prevention.
• Anticholinergic reversal – discontinue offending drugs; consider switching to bladder‑friendly alternatives.
• Antibiotics – administered if a UTI is documented (e.g., nitrofurantoin, trimethoprim‑sulfamethoxazole).

Surgical / Procedural Interventions

• Transurethral resection of the prostate (TURP) – gold standard for obstructive BPH.
• Laser enucleation or vaporization – minimally invasive alternatives.
• Urethral dilatation or internal urethrotomy – for strictures.
• Pelvic floor rehabilitation – in neurogenic cases, combined with biofeedback.

Lifestyle & Supportive Measures

• Fluid intake of 1.5–2 L/day, avoiding caffeine and alcohol excess.
• Timed voiding (every 3–4 hours) to reduce bladder over‑distension.
• Pelvic floor muscle exercises (Kegels) to improve outlet control.
• Reducing constipation with dietary fiber, stool softeners, or regular exercise.

Living with Acute Urinary Retention

Even after the acute episode resolves, patients often need ongoing strategies to prevent recurrence.

• Catheter care – keep the drainage bag below bladder level; change catheter per protocol (usually every 7‑14 days).
• Post‑void residual monitoring – a handheld bladder scanner can be used at home (or during clinic visits) to ensure adequate emptying.
• Medication review – maintain an up‑to‑date list; discuss any new drugs with your pharmacist or urologist.
• Follow‑up schedule – most clinicians see patients 1–2 weeks after catheter removal, then every 3–6 months if BPH is the cause.
• Stay active – regular moderate exercise improves bladder contractility and reduces constipation.

Prevention

Many cases of AUR can be avoided by addressing modifiable risk factors.

1. Prostate health – men over 50 should have annual digital rectal exams and PSA testing as recommended by their physician.
2. Medication vigilance – ask providers to avoid or substitute anticholinergic or strong α‑agonist drugs when possible.
3. Post‑operative care – early mobilization, bladder scanning, and prompt catheter removal after surgery reduce retention risk.
4. Hydration & bowel regularity – aim for 25‑30 g of fiber daily, drink water throughout the day, and treat constipation promptly.
5. Manage chronic diseases – good glycemic control in diabetes and blood pressure control in hypertension help preserve nerve function to the bladder.

Complications

If AUR is not relieved promptly, several serious complications may develop:

• Bladder wall ischemia and eventual fibrosis leading to permanent loss of contractility.
• Upper‑urinary‑tract dilation (hydroureter, hydronephrosis) – can impair kidney function.
• Acute kidney injury (AKI) – reflected by rising creatinine; may become chronic if obstruction persists.
• Urinary tract infection – catheter use increases risk; can progress to pyelonephritis or sepsis.
• Urosepsis – a life‑threatening emergency especially in the elderly or immunocompromised.
• Bladder stones – chronic stasis promotes stone formation.

When to Seek Emergency Care

---

**References**

1. Mayo Clinic. Acute urinary retention. https://www.mayoclinic.org (2023).
2. National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). Urinary Retention. https://www.niddk.nih.gov (2022).
3. Cleveland Clinic. Acute urinary retention: Diagnosis & treatment. https://my.clevelandclinic.org (2024).
4. Urology Care Foundation. Benign Prostatic Hyperplasia (BPH). https://www.urologyhealth.org (2023).
5. World Health Organization. WHO classification of urinary tract infections. https://www.who.int (2022).

```